Sk Biopharmaceuticals Co Ltd Net Asset Momentum
Sk Biopharmaceuticals Co Ltd net asset momentum. Sk Biopharmaceuticals Co Ltd (326030) recorded a net asset momentum of 44.0% as of December 2025, with net assets of ₩826.27 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Sk Biopharmaceuticals Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Sk Biopharmaceuticals Co Ltd (2016–2025)
Net asset momentum of Sk Biopharmaceuticals Co Ltd from 2016 to 2025. This chart tracks Sk Biopharmaceuticals Co Ltd's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +44.0%, with net assets of ₩826.27 Billion KRW as of December 2025. See Sk Biopharmaceuticals Co Ltd (326030) net assets for net asset value and shareholders' equity analysis.
Sk Biopharmaceuticals Co Ltd Net Asset Momentum by Year (2016–2025)
Sk Biopharmaceuticals Co Ltd net asset momentum by year from 2016 to 2025. The table below shows the complete annual net asset history for Sk Biopharmaceuticals Co Ltd from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Sk Biopharmaceuticals Co Ltd market cap and net worth.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩826.27 Billion | ₩1.20 Trillion | ₩372.04 Billion | ▲ +44.0% |
| 2024 | ₩573.98 Billion | ₩1.04 Trillion | ₩462.83 Billion | ▲ +78.8% |
| 2023 | ₩320.95 Billion | ₩723.17 Billion | ₩402.22 Billion | ▲ +1.4% |
| 2022 | ₩316.56 Billion | ₩664.24 Billion | ₩347.68 Billion | ▼ -28.7% |
| 2021 | ₩444.19 Billion | ₩643.65 Billion | ₩199.46 Billion | ▲ +17.2% |
| 2020 | ₩379.07 Billion | ₩500.24 Billion | ₩121.17 Billion | ▲ +3010.2% |
| 2019 | ₩-13.03 Billion | ₩139.07 Billion | ₩152.10 Billion | ▼ -122.2% |
| 2018 | ₩58.63 Billion | ₩95.54 Billion | ₩36.91 Billion | ▲ +24.1% |
| 2017 | ₩47.24 Billion | ₩98.37 Billion | ₩51.12 Billion | ▼ -68.0% |
| 2016 | ₩147.69 Billion | ₩193.89 Billion | ₩46.21 Billion | — |